These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 29644540

  • 1. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.
    Karampatakis T, Antachopoulos C, Tsakris A, Roilides E.
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1211-1220. PubMed ID: 29644540
    [Abstract] [Full Text] [Related]

  • 2. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
    Maniati M, Ikonomidis A, Mantzana P, Daponte A, Maniatis AN, Pournaras S.
    J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142
    [Abstract] [Full Text] [Related]

  • 3. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Hu YF, Liu CP, Wang NY, Shih SC.
    BMC Infect Dis; 2016 Aug 24; 16(1):444. PubMed ID: 27553962
    [Abstract] [Full Text] [Related]

  • 4. Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons.
    Liakopoulos A, Mavroidi A, Katsifas EA, Theodosiou A, Karagouni AD, Miriagou V, Petinaki E.
    BMC Infect Dis; 2013 Oct 29; 13():505. PubMed ID: 24168643
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
    Kim CH, Kang HY, Kim BR, Jeon H, Lee YC, Lee SH, Lee JC.
    J Microbiol; 2016 Jan 29; 54(1):44-49. PubMed ID: 26727901
    [Abstract] [Full Text] [Related]

  • 7. [Molecular Analysis of Antibiotic Resistance in CarbapenemResistant Pseudomonas aeruginosa Isolates Isolated from Clinical Samples].
    Altan G, Rakici E, Özgümüş OB.
    Mikrobiyol Bul; 2024 Apr 29; 58(2):148-170. PubMed ID: 38676583
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons.
    Rojo-Bezares B, Estepa V, Cebollada R, de Toro M, Somalo S, Seral C, Castillo FJ, Torres C, Sáenz Y.
    Int J Med Microbiol; 2014 May 29; 304(3-4):405-14. PubMed ID: 24594145
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.
    Akhi MT, Khalili Y, Ghotaslou R, Yousefi S, Kafil HS, Naghili B, Sheikhalizadeh V.
    Microb Drug Resist; 2018 Mar 29; 24(2):126-135. PubMed ID: 28654368
    [Abstract] [Full Text] [Related]

  • 11. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
    Gutiérrez O, Juan C, Cercenado E, Navarro F, Bouza E, Coll P, Pérez JL, Oliver A.
    Antimicrob Agents Chemother; 2007 Dec 29; 51(12):4329-35. PubMed ID: 17938181
    [Abstract] [Full Text] [Related]

  • 12. Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance.
    Rizek C, Fu L, Dos Santos LC, Leite G, Ramos J, Rossi F, Guimaraes T, Levin AS, Costa SF.
    Ann Clin Microbiol Antimicrob; 2014 Sep 02; 13():43. PubMed ID: 25179208
    [Abstract] [Full Text] [Related]

  • 13. Preferential selection of IMP and VIM metallo-beta-lactamases by imipenem in Pseudomonas aeruginosa.
    Walsh F, Bracher S, Turner P, Amyes S.
    Chemotherapy; 2007 Sep 02; 53(6):407-9. PubMed ID: 17934261
    [Abstract] [Full Text] [Related]

  • 14. Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa.
    Hu Y, Qing Y, Chen J, Liu C, Lu J, Wang Q, Zhen S, Zhou H, Huang L, Zhang R.
    Microbiol Spectr; 2021 Dec 22; 9(3):e0134421. PubMed ID: 34817230
    [Abstract] [Full Text] [Related]

  • 15. Epidemiology and virulence of VIM-4 metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from burn patients in eastern Algeria.
    Meradji S, Barguigua A, Bentakouk MC, Nayme K, Zerouali K, Mazouz D, Chettibi H, Timinouni M.
    Burns; 2016 Jun 22; 42(4):906-18. PubMed ID: 27156788
    [Abstract] [Full Text] [Related]

  • 16. Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
    El-Domany RA, Emara M, El-Magd MA, Moustafa WH, Abdeltwab NM.
    Microb Drug Resist; 2017 Sep 22; 23(6):682-686. PubMed ID: 28085553
    [Abstract] [Full Text] [Related]

  • 17. Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying blaVIM-2, blaVIM-1, blaIMP-8, blaVIM-20 and blaKPC-2.
    PÉrez-VÁzquez M, Sola-Campoy PJ, Zurita ÁM, Ávila A, GÓmez-Bertomeu F, SolÍs S, LÓpez-Urrutia L, GÓnzalez-BarberÁ EM, Cercenado E, Bautista V, Lara N, Aracil B, Oliver A, Campos J, Oteo-Iglesias J, Spanish Antibiotic Resistance Surveillance Program collaborating Group.
    Int J Antimicrob Agents; 2020 Jul 22; 56(1):106026. PubMed ID: 32450200
    [Abstract] [Full Text] [Related]

  • 18. Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure.
    Meletis G, Vavatsi N, Exindari M, Protonotariou E, Sianou E, Haitoglou C, Sofianou D, Pournaras S, Diza E.
    Eur J Clin Microbiol Infect Dis; 2014 Feb 22; 33(2):253-8. PubMed ID: 24062236
    [Abstract] [Full Text] [Related]

  • 19. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece.
    Tsakris A, Pournaras S, Woodford N, Palepou MF, Babini GS, Douboyas J, Livermore DM.
    J Clin Microbiol; 2000 Mar 22; 38(3):1290-2. PubMed ID: 10699045
    [Abstract] [Full Text] [Related]

  • 20. Occurrence of intI1-associated VIM-5 carbapenemase and co-existence of all four classes of β-lactamase in carbapenem-resistant clinical Pseudomonas aeruginosa DMC-27b.
    Jahan MI, Rahaman MM, Hossain MA, Sultana M.
    J Antimicrob Chemother; 2020 Jan 01; 75(1):86-91. PubMed ID: 31647552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.